For example, EVs from cancer stem cells induce increased chemoattraction in MSCs resulting in tumor progression, and EVs from lung cancer cells stimulate the production and secretion of IL-6, IL-8, and monocyte chemoattractant protein-1 in MSCs, thus imbuing MSCs with more tumor-supportive characteristics [98]. The gene discussed is IL6; the disease is neoplasm.